We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CADL market cap is 217.47M. The company's latest EPS is USD -1.1682 and P/E is -5.57.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.86M | -10.32M | -7.9M | -8.57M | -8.76M |
| Net Income | -8.44M | -11.1M | -8.22M | -22.24M | -10.65M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 125k | 125k | 0 |
| Operating Income | -25.73M | -34.72M | -38.39M |
| Net Income | -36.12M | -18.79M | -37.94M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 50.06M | 41.2M | 31.22M | 26.49M | 21.52M |
| Total Liabilities | 27.04M | 28.46M | 25.24M | 36.46M | 36.77M |
| Total Equity | 23.02M | 12.75M | 5.98M | -9.97M | -15.26M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 89.21M | 77.69M | 41.2M |
| Total Liabilities | 25.07M | 29.98M | 28.46M |
| Total Equity | 64.14M | 47.71M | 12.75M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -26.82M | -34.24M | -8.44M | -14.64M | -21.21M |
| Investing | -253k | -280k | -7k | -13k | -13k |
| Financing | N/A | -121k | -1.26M | 690k | 2.37M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.22M | -31.42M | -34.24M |
| Investing | -1.84M | -1.3M | -280k |
| Financing | 71.8M | 19.97M | -121k |
| Market Cap | 217.47M |
| Price to Earnings Ratio | -5.57 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.97 |
| Price to Book Ratio | 16.59 |
| Dividend Yield | - |
| Shares Outstanding | 32.48M |
| Average Volume (1 week) | 783.53k |
| Average Volume (1 Month) | 1.42M |
| 52 Week Change | 477.28% |
| 52 Week High | 14.60 |
| 52 Week Low | 1.16 |
| Spread (Intraday) | 0.03 (0.45%) |
| Company Name | Candel Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.candeltx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
